Ergotamine Drugs Are Latest Target In FDA Crackdown On Unapproved Medications
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA warns eight manufacturers and 12 distributors to stop marketing unapproved drugs that contain ergotamine tartrate.